be irradiated, thereby avoiding the development of RILD. In combination with newer approaches to providing mitotic stimu- lation to the engrafted hepatocytes, regiospecific HIR could pave the way for a safe and highly effective hepatocyte transplantation- mediated treatment regimen for a large number of liver-based inherited metabolic diseases. References 1. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, et al. (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation [see comments]. N Engl J Med 338: 1422–1426. 2. Lake JR (1998) Hepatocyte transplantation [editorial; comment]. N Engl J Med 338: 1463–1465. 3. Dhawan A, Strom SC, Sokal E, Fox IJ (2010) Human hepatocyte transplantation. Methods Mol Biol 640: 525–534. 4. Fisher RA, Strom SC (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82: 441–449. 5. Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, et al. (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111: 1262–1267. 6. Legido-Quigley C, Cloarec O, Parker DA, Murphy GM, Holmes E, et al. (2009) First example of hepatocyte transplantation to alleviate ornithine transcarba- mylase deficiency, monitored by NMR-based metabonomics. Bioanalysis 1: 1527–1535. 7. Waelzlein JH, Puppi J, Dhawan A (2009) Hepatocyte transplantation for correction of inborn errors of metabolism. Curr Opin Nephrol Hypertens 18: 481–488. 8. Gupta S, Bhargava KK, Novikoff PM (1999) Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis 19: 15–26. 9. Soltys KA, Soto-Gutierrez A, Nagaya M, Baskin KM, Deutsch M, et al. (2010) Barriers to the successful treatment of liver disease by hepatocyte transplanta- tion. J Hepatol 53: 769–774. 10. Gupta S, Rajvanshi P, Sokhi R, Slehria S, Yam A, et al. (1999) Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29: 509–519. 11. Yamanouchi K, Zhou H, Roy-Chowdhury N, Macaluso F, Liu L, et al. (2008) Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology 49: 258–267. 12. Grompe M, Laconi E, Shafritz DA (1999) Principles of therapeutic liver repopulation. Semin Liver Dis 19: 7–14. 13. Oertel M, Menthena A, Dabeva MD, Shafritz DA (2006) Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/ progenitor cells. Gastroenterology 130: 507–520. 14. Guha C, Parashar B, Deb NJ, Sharma A, Gorla GR, et al. (2001) Liver irradiation: a potential preparative regimen for hepatocyte transplantation. Int J Radiat Oncol Biol Phys 49: 451–457. 15. Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, et al. (1999) Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59: 5871–5874. 16. Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, et al. (2002) Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36: 354–362. 17. Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, et al. (2005) Feasibility of hepatocyte transplantation-based therapies for primary hyperox- alurias. Am J Nephrol 25: 161–170. Regiospecific Repopulation of the Liver Author Contributions Conceived and designed the experiments: HZ IJF JRC NRC CG. Performed the experiments: HZ XD RK YC YA XW JD LL. Analyzed the data: HZ JRC NRC CG. Contributed reagents/materials/analysis tools: JRC NRC CG. Wrote the paper: HZ IJF JRC NRC CG. 18. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, et al. (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53: 810–821. 19. Dawson LA, Ten Haken RK (2005) Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15: 279–283. 20. Jiang J, Salido EC, Guha C, Wang X, Moitra R, et al. (2008) Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1. Transplantation 85: 1253–1260. 21. Wang X, Mani P, Sarkar DP, Roy-Chowdhury N, Roy-Chowdhury J (2009) Ex vivo gene transfer into hepatocytes. Methods Mol Biol 481: 117–140. 22. Christiansen H, Koenig S, Krause P, Hermann RM, Rave-Frank M, et al. (2006) External-beam radiotherapy as preparative regimen for hepatocyte transplantation after partial hepatectomy. Int J Radiat Oncol Biol Phys 65: 509– 516. 23. Krause P, Wolff HA, Rave-Frank M, Schmidberger H, Becker H, et al. (2011) Fractionated external beam radiotherapy as a suitable preparative regimen for hepatocyte transplantation after partial hepatectomy. Int J Radiat Oncol Biol Phys 80: 1214–1219. 24. Neufeld DS (1997) Isolation of rat hepatocytes.; Pollard JW, editor. Totowa, NJ: Humana Press Inc. 25. Piazza GA, Callanan HM, Mowery J, Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262: 327–334. 26. Roy-Chowdhury N, Roy-Chowdhury J, Wu G, Shouval R, Arias IM (1981) Bilirubin mono- and diglucuronide formation by human liver in vitro: assay by high-pressure liquid chromatography. Hepatology 1: 622–627. 27. Roy-Chowdhury N, Roy-Chowdhury J (2009) Disorders of bilirubin metabo- lism. In: Arias IM, editor. The Liver: Biology and Pathobiology. 5th ed. Chichester, West Sussex, , UK ; Hoboken, NJ: John Wiley & Sons. pp. 251–256. 28. Ambrosino G, Varotto S, Strom SC, Guariso G, Franchin E, et al. (2005) Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 14: 151–157. 29. Dhawan A, Mitry RR, Hughes RD (2006) Hepatocyte transplantation for liver- based metabolic disorders. J Inherit Metab Dis 29: 431–435. 30. Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, et al. (1998) Long-term, near-total liver replacement by transplantation of isolated hepato- cytes in rats treated with retrorsine. Am J Pathol 153: 319–329. 31. Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, et al. (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I [see comments] [published erratum appears in Nat Genet 1996 Apr;12(4):458]. Nature Genetics 12: 266–273. 32. Fevery J, Blanckaert N, Heirwegh KPM, Pre´aux A-M, Berthelot P (1977) Unconjugated Bilirubin and an increased proportion of bilirubin monoconju- gates in the bile of patients with Gilbert’s Syndrome and Crigler-Najjar Disease. J Clin Invest 60: 970–979. PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e46775